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Abstract 16 
 17 
Recent studies report that 35% of women are either overweight or obese at 18 
reproductive age. The placenta continuously releases exosomes across gestation and 19 
their concentration is higher in pregnancy complications. While there is considerable 20 
interest in elucidating the role of exosomes during gestation, important questions 21 
remain to be answered: i) Does maternal BMI affect the exosomal profile across 22 
gestation? and ii) What is the contribution of placenta-derived exosomes to the total 23 
number of exosomes present in maternal plasma across gestation?. Plasma samples 24 
were classified according to the maternal BMI into three groups (n=15 per group): 25 
Lean, overweight, and obese. Total exosomes and specific placenta-derived exosomes 26 
were determined by Nanoparticle Tracking Analysis (NanoSight™) using quantum 27 
dots coupled with CD63 or PLAP antibodies. The effect of exosomes on cytokine (IL-28 
6, IL-8, IL-10 and TNF-α) release from endothelial cells was established by cytokine 29 
array analysis (Bioplex-200). The total number of exosomes present in maternal 30 
circulation was strongly correlated with maternal BMI. Between ~12% and ~25% of 31 
circulating exosomes in maternal blood are of placental origin during gestation, and 32 
the contribution of placental exosomes to the total exosomal population decreases 33 
with higher maternal BMI across gestation. Exosomes increase IL-6, IL-8 and TNF-α 34 
release from endothelial cells, an effect even higher when exosomes were isolated 35 
from obese women compared to lean and overweight. This study established that 36 
maternal BMI is a factor that explains a significant component of the variation in the 37 
exosomes data. Exosomes may contribute to the maternal systemic inflammation 38 
during pregnancy. 39 
 40 
 41 
 42 
  43 
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Background 44 
 45 
Obesity is one of the largest and most serious health issues we face today [1]. The 46 
Centers for Disease Control and Prevention has reported that in the 2011-2012 period 47 
over 35% of adults 20 years and over were considered obese, and 69% were 48 
considered either obese or overweight. In the USA, about 1 in 3 women of 49 
reproductive age is obese and the numbers are steadily increasing [2]. This poses a 50 
serious problem as studies have shown that obesity is linked to complications for 51 
pregnant women and their babies, including metabolic syndrome [3]. For the women, 52 
obesity may result in induced preterm delivery, gestational diabetes, miscarriages, and 53 
preeclampsia, while for the babies obesity in the mother may result in complications 54 
such as fetal death and birth defects [4-7].  55 
Maternal health and microenvironment have direct and significant impacts on the 56 
fetus during development as well as an impact on subsequent adult health. The 57 
maternal microenvironment is influenced by a number of factors, with the placenta 58 
being a unique contributor. Interestingly, women with gestational diabetes have a 59 
higher probability of having a large placenta, a phenomenon even higher in obese 60 
women [8]. Moreover, placental efficiency (ratio of fetal to placental weight) is lower 61 
in overweight and obese women compared to lean women [9]. These data suggest that 62 
maternal metabolic status affects placental function and may modify the release of 63 
placental factors into maternal circulation. The placenta releases a wide range of 64 
molecules, including hormones, cytokines, and extracellular vesicles (EVs). 65 
 66 
Recently, much attention has focused on the role of placenta-derived EVs during 67 
gestation [10] and specifically, on exosomes [11]. Exosomes are membrane-bound 68 
nanovesicles of around 100 nm diameter that transport molecular signals (consisting 69 
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of proteins, bioactive lipids, and RNAs) between cells; they are released from a wide 70 
range of cells, including the human placenta. Exosomes are of endosomal origin and 71 
formed by the inward budding of multivesicular bodies (MVB) and are released to the 72 
extracellular environment by the fusion of MVB with the plasmatic membrane at the 73 
end of the endocytic-recycling pathway. As such, they are enriched with late 74 
endosomal membrane markers, including, Tsg101 and enriched in members of the 75 
tetraspanin family such as CD63, CD9, and CD81 [12]. 76 
 77 
Exosomal signaling represents an integral pathway mediating intercellular 78 
communication.  During pregnancy, the placenta releases exosomes into the maternal 79 
circulation from as early as 6 weeks of gestation [13] and the concentration of 80 
placenta-derived exosomes during third trimester is positively correlated with 81 
placental weight at delivery under normal gestation [14]. Interestingly, the release of 82 
exosomes from trophoblast cells at early gestation (i.e. ~10 weeks) is regulated by the 83 
microenvironment milieu, including oxygen tension and glucose concentration [15-84 
17]. Recent studies highlight the putative utility of exosomes for the diagnosis of 85 
disease and the onset of complication of pregnancies. For example, the gestational 86 
profile of exosomes concentration in plasma is different in gestational diabetes 87 
compared to normal pregnancy [18]. Taken together, these results support the 88 
hypothesis that placenta-derived exosomes are regulated by environmental factors, 89 
and may play a role in feto-maternal communication under both normal and 90 
pathological conditions. 91 
Maternal obesity is associated with endothelial cell dysfunction [19]. Endothelial cell 92 
dysfunction can be related to obesity through factors such as hormones, fat-derived 93 
metabolic products, as well as cytokines. These adipocyte-derived products can have 94 
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an impact on vascular function as well as inducing insulin resistance. Free fatty acids 95 
have been associated with impaired vascular reactivity, an indicator of endothelial 96 
dysfunction [20]. TNF-α is another factor that may play a role in endothelial cell 97 
dysfunction; however, the mechanism is still unclear [21]. Many studies focusing on 98 
cytokines IL-1 and IL-6 have related them to endothelial dysfunction as well as 99 
subclinical inflammation [22]. For instance, IL-6 stimulates the production of C-100 
reactive protein (CRP) in the liver, which leads to inflammation and impacts the 101 
vascular wall. Steinberg et al. showed that subjects with Type 2 DM has the same 102 
degree of impairment in vascular reactivity and blood flow as compared with obese 103 
subjects with normal glucose tolerance and insulin resistance [23]. Interestingly, we 104 
have previously described that exosomes present in maternal circulation regulates the 105 
function of endothelial cells including cell migration [14] and secretion of cytokines 106 
[18], however, the impact of maternal BMI on the effect of exosomes on endothelial 107 
cells has not been established. 108 
There is now increasing evidence that maternal BMI alters the placental function [24] 109 
and that pregnancy is associated with maternal systemic inflammation, a state even 110 
higher in obese women [24]. There are no studies, however, that have defined the 111 
relationship between maternal BMI and placenta-derived exosome concentration 112 
during gestation. Thus, the aim of this study was to establish the relationship between 113 
maternal Body Mass Index (BMI) and exosomes present in maternal circulation 114 
during gestation. Moreover, we established the contribution of placental exosomes to 115 
the total exosomes concentration present in maternal circulation during gestation and 116 
the effect of exosomes on cytokines released from endothelial cells. The data of this 117 
study established that maternal BMI is a factor that explains a significant component 118 
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of the variation in the total exosomes and placenta-derived exosomes concentration 119 
present in maternal circulation during gestation. 120 
 121 
 122 
 123 
 124 
Methods 125 
 126 
Study group and samples 127 
A time-series study design was used to establish the relationship between 128 
maternal BMI and exosome concentration during pregnancy.  Women were recruited 129 
between January 2013 and December 2013 with informed written consent, at the 130 
Ochsner Baptist Medical Center (New Orleans, USA). Blood samples (BD 131 
Vacutainer® PLUS Tubes EDTA) were obtained from pregnant women at different 132 
times of gestation (10-38 weeks) and classified according to maternal BMI into lean 133 
(n=15, BMI 18.5-24.9 Kg/m2), overweight (OW, n=15, BMI 25-29.9 Kg/m2), and 134 
obese (n=15, BMI >30 Kg/m2) at the moment of sample collection. Gestational age 135 
was calculated from the first day of the last menstrual period. All pregnant women 136 
included in this study were normotensive and without intrauterine infection or any 137 
other medical or obstetric complications. Plasma samples were obtained in 138 
accordance with the declaration of Helsinki and approved by the Ethics Committee of 139 
The University of Queensland and the Ochsner Medical Center (New Orleans, USA). 140 
Plasma was separated from whole blood by centrifugation (2000g x 10 min at Room 141 
temperature) and stored at -80oC until analyses.  All experimental procedures were 142 
conducted within an ISO17025 accredited (National Association of Testing 143 
Authorities, Australia) research facility.  All data were recorded within a 21 Code of 144 
Federal Regulation (CFR) part 11 compliant electronic laboratory notebook (Lab 145 
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Archives, Carlsbad, CA 92008, USA). The schematic in Figure S1 summarizes the 146 
experimental design used in this study 147 
 148 
 149 
Isolation of exosomes from maternal circulation  150 
Exosomes were isolated from plasma (1 ml) as previously described [13, 14, 18] 151 
(Figure S2). The 100,000 g pellet was resuspended in 500 µl PBS and stored -80oC 152 
until exosome purification using a discontinuous iodixanol gradient (Supplemental 153 
Material and Methods). We have previously confirmed the stability of exosomes after 154 
a freeze and thaw cycles using fresh and frozen samples [13]. 155 
 156 
 157 
Quantification of total exosomes and placenta-derived exosomes by Nanoparticle 158 
Tracking Analysis (NTA) 159 
The concentration of total and placenta-derived exosomes in maternal plasma was 160 
quantified using CD63 and Placental Alkaline Phosphatase (PLAP) by 161 
immunofluorescent NTA. PLAP is a syncytiotrophoblast-specific marker, therefore, 162 
exosomes derived from placental origin are positive for PLAP [14]. Qdots (Qdot® 163 
nanocrystals or R-PE) were conjugated to anti-CD63, anti-PLAP or IgG1 isotype 164 
control antibody (IgG1 sc-34665, Santa Cruz Biotechnology) with a SiteClick Qdot 165 
605 Antibody Conjugation Kit (Life Technologies) according to the manufacturer’s 166 
instructions as previously described [25]. Exosomes were diluted in PBS and 167 
incubated with FcR blocking reagent (10 µl, 10 min at 40C) (MACS Miltenyi Biotec), 168 
followed by incubation with anti-CD63-Qdot605 or anti-PLAP-Qdot605 or IgG1-169 
Qdot605 (10 µl, 1:100) for 30 min in the dark at room temperature. Samples were 170 
then diluted to 500 µl with PBS and analyzed using the NanoSight NS500 instrument 171 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 8
and NTA software. Samples were analyzed using fluorescence mode (i.e. camera 172 
level 9, shutter speed 11.25 ms and slider gain 250). Five videos x 60 sec each were 173 
captured for each sample and analyzed. The specificity of the Qdot-PLAP in binding 174 
only exosomes from the placenta was measured using exosomes isolated from first 175 
trimester trophoblast cells (positive control; Supplemental Material and Methods) and 176 
exosomes isolated from plasma obtained from non-pregnant women (negative 177 
control). 178 
 179 
Endothelial cells isolation 180 
Primary human umbilical vein endothelial cells (HUVEC) were isolated by enzymatic 181 
digestion as previously described [17] and used as an in vitro model to determine the 182 
effect of BMI on the internalization of exosomes and cytokine release (Supplemental 183 
Material and Methods). HUVEC were isolated from placenta obtained from term 184 
pregnancies (>37 weeks). To discard the effect of maternal BMI on the response of 185 
HUVEC to exosomes, only HUVEC from placenta obtained from lean women (BMI 186 
18.5-24.9 Kg/m2) were used in this study. 187 
 188 
Effect of BMI on exosome-induced cytokine release from endothelial cells  189 
To determine the effect of BMI on exosome-induced cytokine release, exosomes (100 190 
µg protein/ml which is equivalent to 5 x 108 vesicles per ml) were incubated with 191 
primary human umbilical vein endothelial cells (HUVECs) in medium containing 192 
5mM D-glucose. The experiments were performed at an atmospheric pressure of 8% 193 
O2 to mimic the physiological conditions (oxygen tension in human blood is normally 194 
between 10% to 13%[26]). The association between total number of exosomes and 195 
protein concentration was determined by correlation analysis (Pearson r = 0.99; R2 = 196 
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0.98; ***p value = 0.0010). Cytokine release (defined as the accumulation of 197 
immuno-reactive cytokine in cell conditioned medium) was quantified using protein 198 
solution arrays. Data are expressed as cytokine pg /103 cells/24h and normalized to 199 
the level of cytokines in cell-conditioned media without exosomes (control). 200 
 201 
Internalization of Exosomes  202 
The internalization of exosomes by endothelial cells was assessed as previously 203 
described [27] using fluorescently labeled (PKH67 green, Sigma-Aldrich) exosomes. 204 
A live-cell imaging system (The Incucyte FLR fluorescent) was used for continuous 205 
tracking of exosome internalisation in endothelial cells (Supplemental Material and 206 
Methods).  207 
 208 
Statistical analysis  209 
The relationship between maternal BMI and exosome concentration present in plasma 210 
was assessed using 2-way ANOVA, with the variance partitioned between gestational 211 
age and maternal BMI, thus, maternal BMI was treated as an independent factor. In 212 
this study, we did not find a statistically significant association between gestational 213 
age and maternal BMI (p>0.05; Supplemental material Figure S3), therefore, multiple 214 
regression analyses of 3 continuous variables (i.e. dependent variable: Exosomes; 215 
independent variables: gestational age and maternal BMI) was also used. Statistical 216 
significance was defined as at least p <0.05.  Statistical analyses were performed 217 
using commercially available packages (Stata 11, StatCorp, College Station, Texas 218 
 USA and Prism 6, GraphPad Inc, La Jolla, CA 92037 USA).  219 
 220 
Results  221 
 222 
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Exosome isolation and characterization.  223 
The characteristics of exosomes isolated and purified using a well-established and 224 
validated method are presented in Supplemental Figure S2.  Nanoparticle tracking 225 
analysis identified particles with sizes of ~100 nm (Figure 1A) without significant 226 
differences between Lean, OW, and obese women.  Morphological analysis identified 227 
circulate shape characteristics of exosomes (Figure 1B) and enrichment of the CD63 228 
protein abundance (Figure 1C). The total number of particles was quantified under 229 
light scatter mode and the vesicles positive for CD63 (enriched marker associated 230 
with exosomes) and for PLAP (placental origin) were quantified under fluorescence 231 
mode using nanocrystals (Qdot) coupled with CD63 or PLAP, respectively. No effect 232 
on the size distribution of exosomes present in maternal circulation was identified in 233 
light scattering mode or fluorescence mode (i.e. CD63+ or PLAP+), showing that the 234 
exosome-Qdot binding did not affect the vesicles characteristics. A similar number of 235 
particles were identified in light scatter in the absence and in the presence of Qdot-236 
IgG (~90% i.e. nonspecific binding of ~10%). The percent of vesicles positive for 237 
CD63 in the total vesicle population (defined as total vesicles in light scatter mode) 238 
was 88 ± 8.9 % (Figure 1 D), indicating that the majority of the isolated vesicles are 239 
positive for CD63. The specificity of Qdot-PLAP in binding only vesicles PLAP 240 
positive was evaluated using exosomes isolated from syncytiotrophoblast (ST) cells 241 
and exosomes isolated from non-pregnant women (Figure 1E and F). No significant 242 
differences were obtained between the quantification exosomes from ST in light 243 
scatter and fluorescence mode (Qdot-PLAP), indicating that the binding was over 244 
90%. On the other hand, particles positive for PLAP were not found in exosomes 245 
isolated from plasma obtained from non-pregnant women (<5% = unspecific 246 
binding).    247 
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 248 
Relationship between maternal BMI and exosomes. 249 
This study sample consisted of 45 pregnant women. These women were categorized 250 
according to their BMI into lean (reference group), OW, and obese. Clinical 251 
characteristics of the patients are present in Table 1. 252 
Pooled exosome-containing fractions (i.e. fractions 5 to 8; Supplemental material 253 
Figure S2) were further characterized by determining the total number of exosomes 254 
and PLAP exosomes present in maternal circulation across gestation (Figure 2).  The 255 
relationship between maternal BMI and gestational age variation in plasma exosome 256 
number and placental exosomes were analyzed by two-way ANOVA with the 257 
variance partitioned between gestational age and BMI.  Significant effects of 258 
gestational age and maternal BMI were identified (p<0.005) (Figure 2). Linear 259 
regression analysis showed that both total exosomes and placental exosomes 260 
increased progressively across gestation from 10 to 38 weeks, and this was 261 
independent of the maternal BMI. (Figure 2A and B).  The slopes of the regression 262 
lines (± SD) for exosome concentration per gestational age data for lean and OW 263 
women were 4.7 x 107 ± 3.3 x 106 and 4.2 x 107 ± 9.2 x 106, respectively; and 264 
significantly different (p <0.001) from the slope for obese women  (6.3 x 107 ± 1.4 x 265 
107). The slopes of the regression lines (± SD) for placental exosomes concentration x 266 
gestational age data for lean, OW women were 9.2 x 106 ± 5.7 x 105 and 7.2 x 106 ± 267 
1.5 x 106, respectively; and significantly different (p <0.001) than the slope for obese 268 
women (1.3 x 107 ± 2.9 x 106). The relationship between maternal BMI and exosomes 269 
present in maternal circulation is presented in Figure 3. Interestingly, the total number 270 
of exosomes present in maternal circulation was strongly correlated with maternal 271 
BMI (Figure 3A). Placenta-derived exosomes were positively correlated with 272 
maternal BMI, but without a statistical significant difference (p=0.135) (Figure 3B).   273 
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  274 
Contribution of placental-derived exosomes to total exosomes present in 275 
maternal plasma across gestation. 276 
Linear regression analysis showed that the percentage of placental exosomes present 277 
in maternal circulation negatively correlated with maternal BMI (Figure 4A). We then 278 
determined the variation in the contribution of placenta-derived exosomes in maternal 279 
circulation during gestation (Figure 4B). The contribution of placenta-derived 280 
exosomes increases with gestational age (p<0.05), however, we did not find a 281 
correlation between placenta-derived exosomes in maternal circulation with 282 
gestational age in OW and obese women. No significant relationship between 283 
exosomes (total or placenta-derived) and fetal sex has been found. 284 
 285 
Effect of exosomes on cytokine release from endothelial cells 286 
Exosomes increase IL-6, IL-8, and TNF-α release from endothelial cells in all the 287 
conditions studied and were significantly higher when exosomes were isolated from 288 
obese women (Figure 5). Interestingly, a positive correlation (p<0.05) was found 289 
between cytokine release and gestational age (at the moment of sample collection) for 290 
IL-6 (lean and obese) and TNF-α (lean and obese). Interestingly, a negative 291 
correlation was found between IL-6 and gestational age using exosomes from obese 292 
pregnant women (Figure 5A, C, E). No effect of exosomes (lean, OW or obese) on 293 
IL-10 release was identified (Figure 5G and H).  The effect of exosomes (average 294 
combined gestational age) on IL-6 release was 2.0 ± 0.4, 1.6 ± 0.7, and 3.3 ± 1.3 fold 295 
higher compared to the control (without exosomes) for lean, OW, and obese, 296 
respectively (Figure 5B), on TNF-α release was 2.3 ± 0.5, 3.8 ± 0.9, and 4.4 ± 1.0 fold 297 
higher compared to the control (without exosomes) for lean, OW, and obese, 298 
respectively (Figure 5D) and on IL-8 release, was 1.3 ± 0.3, 1.8 ± 0.3, and 2.8 ± 0.3 299 
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fold higher when compared to the control (without exosomes) for lean, OW, and 300 
obese, respectively (Figure 5F). 301 
 302 
Finally, the internalization of exosomes labeled with PKH67 (green) in endothelial 303 
cells was visualized and quantified using fluorescence microscopy and real time cell 304 
imaging (The IncuCyte,), respectively (Figure S4). Exosome uptake by endothelial 305 
cells was observed in a time-dependent manner with the maximum at 24 h. The rate 306 
of exosome uptake was compared using the half-maximal stimulatory time (ST50). We 307 
did not find differences in the ST50 for the exosomes internalization between 308 
exosomes isolated from lean, OW, and obese women. 309 
 310 
 311 
 312 
 313 
Discussion 314 
 315 
The field of exosomes-mediated cell-to-cell communication is a burgeoning field and 316 
may provide unique insights into the aetiology of disease, early detection, and 317 
treatment monitoring. Excessive weight and obesity are recognized as important 318 
public health issues worldwide; recent findings show that 35% of women aged 25-35 319 
years of age (reproductive age) are overweight or obese [28]. In fact, excess weight 320 
and obesity are the most powerful drivers for the onset and development of 321 
complication in pregnancies with both short and long term consequences for both the 322 
mother and child [29]. In the presented study, we investigated the effect of maternal 323 
BMI on the exosomal profile during gestation. The concentration of total exosomes 324 
and placental exosomes present in maternal circulation were different in obese women 325 
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compared to lean or OW women. Interestingly, obese women present a higher 326 
concentration of total exosomes and placental exosomes in maternal circulation across 327 
gestation. Moreover, in this study we have partially answered the question about the 328 
contribution of placental exosomes to the total exosomal population in maternal 329 
circulation during pregnancy. This study established that the contribution of placental 330 
exosomes (expressed as percentage of exosomes positive for PLAP compared to total 331 
exosomes) did not change significantly across gestation. Placental-derived exosomes 332 
present in maternal circulation were ~12% at early gestation (i.e. ~10-12 weeks) and 333 
increased during pregnancy until ~20% at third trimester (i.e. >32 weeks). Finally, 334 
exosomes present in maternal circulation during gestation may contribute to the 335 
maternal systemic inflammation during pregnancy, an event of significantly higher 336 
incidence in obese women. 337 
 338 
Exosomes are well thought of as a “fingerprint” of their cell origin and their 339 
metabolic status. In other words, isolation and characterisation of placental exosomes 340 
present in maternal circulation can be considered as a non-invasive biopsy of 341 
placental cells. Several studies have demonstrated that maternal BMI affects 342 
pregnancy outcomes with long-term consequences for the offspring [30-32]. To our 343 
knowledge, this is the first study to identify maternal BMI-associated changes in the 344 
exosomes concentration across gestation.  345 
 346 
In this study, we used a well-established and validated method to obtain an enriched 347 
exosome fraction using buoyant density centrifugation to minimize the contribution 348 
from other extracellular vesicles. Total exosomes and placental exosomes increase 349 
progressively with the pregnancy progression (Figure 2), an effect higher in obese 350 
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pregnancies. Interestingly, we have previously described an association between 351 
placental weight and exosomal PLAP (an indirect measurement of placental 352 
exosomes) at third trimester of pregnancy [14]. In this study, we did not record the 353 
placental weight, therefore, the relationship between maternal BMI, placental weight 354 
or placental efficiency and exosomes concentration requires future studies. However, 355 
no interaction between maternal BMI and placental weight has been previously 356 
described [9].  357 
Supporting our results, we have previously showed that the concentration of placental 358 
exosomes in maternal circulation increases across gestation [14]. We quantified the 359 
total number of exosomes and placenta-derived exosomes using the method described 360 
by Dragovic et al., using fluorescence nanoparticle tracking analysis [25], that gave us 361 
the opportunity to measure individual vesicles and determine the contribution of 362 
exosomes from placental origin to the total exosome population.  363 
Higher levels of total and placental exosomes were reported in this study in obese 364 
women compared to lean and overweight women, which may be due to obesity being 365 
associated with pro-inflammatory state causing a higher secretion of exosomes.  366 
Interestingly, the capacity of exosomes present in maternal circulation across 367 
gestation to regulate the pro-inflammatory cytokine secretion from endothelial cells 368 
was significantly higher using exosomes from obese and OW women when compared 369 
to lean women. These outcomes are consistent with previous studies in which levels 370 
of IL-6 and TNF-α increase across gestation [33]. IL-6 is a pro-inflammatory cytokine 371 
secreted pre-dominantly by adipocytes, macrophages, skeletal muscle, endothelial 372 
cells and fibroblasts. IL-6 has been associated with obesity and affecting glucose 373 
metabolism [34, 35]. During gestation, IL-6 regulates embryo implantation and 374 
placental development; enhances the secretion of human chorionic gonadotropin 375 
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(HCG) from trophoblast cells HCG and mediating inflammation and induces insulin 376 
resistance [36-41]. High levels of TNF-α are associated with maternal systemic 377 
inflammation and obesity [42]. During gestation, higher levels of TNF-α in maternal 378 
plasma lead to complications of pregnancies including gestational diabetes [43]. 379 
Interestingly, our data established that the effect of exosomes on the secretion of 380 
TNF-α was higher at late gestation (Figure 5C). TNF-α has been shown to impact 381 
parturition [44], however, the effect of exosomes on signal of parturition has not been 382 
established yet. While the mechanisms controlling the concentration of cytokines in 383 
maternal circulation during gestation remain unclear, we suggest that exosomes may 384 
have a role regulating the concentration of cytokines (e.g. IL-6 and TNF-α) during 385 
gestation.  386 
 387 
Maternal BMI is a risk factor for the development of gestational diabetes mellitus 388 
(GDM) [45], a phenomenon associated with maternal systemic inflammation [24]. 389 
Interestingly, we have recently reported that the concentration of placental exosomes 390 
in GDM pregnancies is higher when compared to normal pregnancies [18]. Moreover, 391 
exosomes isolated from GDM pregnancies increase the pro-inflammatory cytokines 392 
release (e.g TNF-α) from endothelial cells compared to exosomes isolated from 393 
normal pregnancy [18]. Recently, Aye et al., reported elevated levels of pro-394 
inflammatory cytokines in maternal circulation and activation of placental p38-395 
MAPK and STAT3 pathways with increasing maternal BMI [24]. These findings 396 
suggest that increased maternal BMI is associated with maternal pro-inflammatory 397 
state affecting both maternal tissues and placenta, which may be due to elevated 398 
exosomes (total and placental) in maternal circulation.  399 
 400 
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In this study, we demonstrated that maternal BMI is a factor that explains for >20% of 401 
the observed variation in plasma exosomes concentration (Figure 3). These 402 
observations give rise to the question: how does maternal BMI increase the exosome 403 
concentration in maternal circulation? Exosomes are a subtype of EVs with specific 404 
biogenesis and secretion mechanisms that are not fully understood. Exosomes are a 405 
product of endosomal trafficking in which intraluminal vesicles (ILVs) are 406 
incorporated into multivesicular bodies (MVB) and then released via exocytosis as 407 
exosomes to the microenvironment milieu by the transport and fusion of MVB with 408 
the plasmatic membrane. Recent studies have shown that the endosomal-sorting 409 
complex required for transport (ESCRT) and TSG101 protein are required for the 410 
exosome secretion from HeLa cells [46]. The expression of these proteins in placental 411 
cells obtained from women with different metabolic status (e.g. obese and 412 
overweight) has not been established yet. Interestingly, the RAB family of small 413 
GTPase proteins have been implicated in the intracellular vesicular tracking [47]. 414 
RAB proteins are expressed in the human placenta [48], however, the expression of 415 
these proteins in placentas obtained from obese or overweight women has not been 416 
studied. Interestingly, RAB protein has been implicated in lipid storage and insulin-417 
regulated GLUT-4 trafficking in adipose tissue. Hypoxia and high glucose are other 418 
factors that increase the exosome release from placental cells [15-17]. Recently, 419 
Wang et al., demonstrated that hypoxia increases the expression of RAB22A involved 420 
the activation of hypoxia-inducible factors (HIFs), which results in an increase in the 421 
secretion of microvesicles from breast cancer cells [49]. Thus, RAB proteins are 422 
involved in the secretion of exosomes from placental cells to maternal circulation in 423 
response to increasing maternal BMI requires further investigation. 424 
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In this study, the levels of circulating exosomes in maternal plasma were significantly 426 
higher in obese women compared to normal or overweight women.  We suggest that 427 
maternal BMI modulates the exosome secretion from placental cells and maternal 428 
sources, however, we cannot ignore that maternal BMI modifies the clearance or half-429 
life of circulating exosomes. Recently, it has been proposed that macrophages play a 430 
crucial role in the clearance of exosomes from the body [50]. Imai et al., 431 
demonstrated that the clearance of exosomes is significantly lower in macrophage-432 
depleted mice compared to mice control.  The placenta-derived exosomes clearance 433 
has not been established, however, the levels of placental miRNA, which are secreted 434 
from placental cells into exosomes, decrease dramatically after delivery [51].  435 
 436 
Conclusions 437 
In this study we have established that i) maternal BMI modulated the exosome 438 
concentration in maternal circulation across gestation; ii) 12% to 25% of the 439 
circulating exosomes in maternal plasma during gestation are from placental origin; 440 
and iii) exosomes isolated from maternal circulation increase the pro-inflammatory 441 
cytokines releases from endothelial cells, and strongly positively correlated with 442 
maternal BMI. Take all together, we suggest that exosomes may have a role in the 443 
chronic metabolic inflammatory state associated with obesity.  444 
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Table 1.  Clinical characteristics of patients and newborns 635 
 636 
Maternal Variables 
 Lean 
(n=15) 
OW 
(n=15) 
Obese 
(n=15) 
ANOVA 
Maternal age (years) 29 ± 3.9 
(23-36) 
30 ± 5.3 
(20-37) 
29 ± 6.4 
(20-41) 
0.1251 
Height (cm) 163  ± 0.6 
(155-172) 
161  ± 0.7† 
(154-175) 
165  ± 0.7* 
(152-175) 
<0.001 
Weight (Kg) 60  ± 6.3  
(50-73) 
71  ± 9.3†  
(64-90) 
92  ± 10* 
(72-110) 
<0.001 
BMI (Kg/m2) 22  ± 1.6 
(19-24) 
28  ± 1.3† 
(25-29) 
34  ± 3.8* 
(30-42) 
<0.001 
Gestational age (weeks) 22  ± 3.5 
(11-36) 
23  ± 2.6 
(12-38) 
24  ± 2.8 
(10-38) 
0.2524 
Gestational age at 
delivery (weeks) 
39  ± 1.2 
(37-41) 
38 ± 0.9 
(38-40) 
39  ± 1.1 
(38-40) 
0.0656 
Type of delivery (% 
caesarean/ %vaginal) 
4/11 5/10 7/8 (-) 
Newborn variables 
Fetal weight (g) 3307  ± 424 
(2892-4167) 
3261  ± 408 
(2756-3714) 
3517  ± 524 
(2972-4217) 
0.3463 
Fetal sex (male/female) 9/6 10/5 10/5 (-) 
 637 
 638 
Data are presented as mean ± SD (range). Groups were classified according to the maternal 639 
BMI in lean, overweight (OW), and obese. Maternal age, height, weight, BMI and gestational 640 
age are presented at the time of sample collection. This study was designed to include only 641 
normal pregnancies. Maternal BMI was calculated as weight (kg) divided by height (m2) at 642 
the time of sample collection. *p < 0.05 versus OW or lean; †p < 0.05 versus lean. (-) Not 643 
applicable. 644 
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Figures legends 646 
 647 
  648 
Figure 1.  Characterisation of exosomes present in maternal circulation.  Plasma 649 
samples were obtained from women with different metabolic states and classified into 650 
lean, overweight (OW), and obese. Exosomes were isolated from plasma as was 651 
indicated in Methods and characterised using nanoparticle tracking analysis, electron 652 
microscopy, and western blot. (A) Representative size distribution of exosomes in 653 
light scatter mode. (B) Representative electron micrograph of exosomes. (C) 654 
Representative Western blot for exosome enriched marker CD63. (D) NTA 655 
Comparison between light scatter mode and fluorescence mode (Qdot-CD63) in 656 
exosomes isolated from maternal plasma. (E) NTA Comparison between light scatter 657 
mode and fluorescence mode (Qdot-PLAP) in exosomes isolated from 658 
Syncytiotrophoblast cells and (F) from non-pregnant women (see supplemental 659 
material). In B, Scale bar 100 nm and arrows indicate the exosomes. 660 
 661 
 662 
Figure 2. Relationship between maternal BMI and exosome concentration across 663 
gestation. Enriched exosome populations were quantified using nanoparticle tracking 664 
analysis in fluorescence mode in peripheral plasma of lean, overweight (OW), and 665 
obese women across gestation. (A) Linear regression analysis between total exosomes 666 
number presented as total vesicles CD63+ per l ml of plasma across gestation. (B) 667 
Linear regression analysis between placenta-derived exosomes number presented as 668 
total vesicles PLAP+ per l de plasma across gestation.  669 
 670 
Figure 3. Relationship between number of exosomes and maternal BMI. We used 671 
multivariate linear regression analysis to evaluate the relationship between exosomes 672 
and maternal BMI. (A) Relationship between total exosomes (total vesicles CD63+) 673 
and maternal BMI. (B) Relationship between placenta-derived exosomes (vesicles 674 
PLAP+) and maternal BMI. In A and B, Lineal correlation (-) and 95% confidence 675 
interval (--). 676 
 677 
Figure 4. Contribution of placental-derived exosomes into maternal circulation 678 
across gestation. The ratio of placental exosomes and total exosomes present in 679 
maternal circulation across gestation was quantified using nanoparticle tracking 680 
analysis in fluorescence mode and presented as percentage (%) of exosomes PLAP+ 681 
to total exosomes CD63+. (A) linear regression analysis between percentage of 682 
placenta-derived exosomes and maternal BMI. (B) Contribution of placenta-derived 683 
exosomes across gestation.  684 
 685 
Figure 5. Induction of cytokine release from endothelial cells by exosomes. Effect 686 
of exosomes  (100 µg/ml) isolated from plasma obtained from lean, overweight (OW), 687 
and obese women across gestation on the release of IL-6 (A and B), TNF-α (C and 688 
D), IL-8 (E and F), and IL-10 (G and H) from endothelial cells. In A, C, E, and G the 689 
data is presented as XY graph where each point is defined as the fold change on 690 
cytokine release in the presence of exosomes compared to control (without exosomes) 691 
and the gestational age at the moment to collect the sample in which the exosomes 692 
were isolated. Red line represents no difference between exosomes and the control. 693 
Lines represents liner correlation for lean, OW (-), and obese (--) exosomes. In B, D, 694 
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F, and H data is present as the fold change in average on the effect of exosomes on 695 
cytokines release across gestation. 696 
 697 
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Highlights 
 An association between maternal BMI and exosomes has been established. 
 
 Total and placental exosomes increase with higher maternal BMI. 
 
 ~20% of circulating exosomes in the mother are from placental origin. 
 
 Exosomes from obese pregnant women induce cytokine release. 
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